A CD16/CD30 bispecific monoclonal antibo
โ
Andreas Hombach; Wolfram Jung; Christoph Pohl; Christoph Renner; Ugur Sahin; Rud
๐
Article
๐
1993
๐
John Wiley and Sons
๐
French
โ 808 KB
In order to target NK cells against the Hodgkin's-derived cell line L540, we developed bispecific monoclonal antibodies (Bi-MAbs) by somatic hybridization of the 2 mouse hybridoma cell lines HRS-3 and A9 which produce monoclonal antibodies (MAbs) with reactivity against the Hodgkin and Reed-Sternber